Medical Devices

Image

Global Glycomics/Glycobiology Market – Industry Trends and Forecast to 2029

  • Medical Devices
  • Upcoming Report
  • Aug 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Glycomics/Glycobiology Market – Industry Trends and Forecast to 2029

Market Size in USD Billion

CAGR - % Diagram

Diagram Forecast Period 2021–2029
Diagram Market Size (Base Year) USD 16.40 Billion
Diagram Market Size (Forecast Year) USD 47.44 Billion
Diagram CAGR %

Global Glycomics/Glycobiology Market, By Product (Enzymes, Kits, Reagents and Chemicals, Instruments, Carbohydrates), Application (Drug Discovery and Development, Disease Diagnostics, Other Application), End User (Academic Research Institutes, Pharmaceutical and Biotechnology Companies, Clinical Laboratories) – Industry Trends and Forecast to 2029.

Glycomics/Glycobiology Market Analysis and Size

One of the most frequent alterations for cell survival is the attachment of glycans. Two types of glycosylation exist. One is N-linked glycosylation: Asparagine glycan attachment and other is O-linked glycosylation: when the glycan is connected to a serine or threonine. Glycomics is a rapidly developing scientific subject that focuses on explaining how glycans operate in biosystems.

Data Bridge Market Research analyses that the glycomics/glycobiology market which was USD 16.4 billion in 2021, would rocket up to USD 47.44 billion by 2029, and is expected to undergo a CAGR of 14.2% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Glycomics/Glycobiology Market Scope and Segmentation      

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2014 - 2019)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Product (Enzymes, Kits, Reagents and Chemicals, Instruments, Carbohydrates), Application (Drug Discovery and Development, Disease Diagnostics, Other Application), End User (Academic Research Institutes, Pharmaceutical and Biotechnology Companies, Clinical Laboratories)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Merck KGaA (Germany), Agilent Technologies Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Shimadzu Corporation (Japan), Takara Bio Inc. (Japan), Waters Corporation (U.S.), Asparia Glycomics S.L. (Spain), Bio-Techne (U.S.), Bruker (U.S.), Danaher (U.S.), RayBiotech, Life Inc.  (U.S.), Z Biotech LLC (U.S.), Chemily Glycoscience (U.S.), Dextra Laboratories Ltd. (U.K.), Lectenz Bio (U.S.), and Ludger Ltd. (U.K.)

Market Opportunities

  • Rising investments in research and development
  • Increasing interest in proteomics examination

Market Definition

The study of saccharides, which are extensively distributed in nature and are also thought as glycans, and their structure, biology, and function is known as glycomics or glycobiology. Each and every living thing contains glycans. Biotechnology, biomedicine, and basic research are all interested in glycobiology's rapidly developing biological topic.

Glycomics/Glycobiology Market Dynamics

Drivers

  • Technological advancements

Technological advancements are thought to promote corporate expansion. Other important aspects that operate as determinants include rising analysis spending by various administration groups and the development of novel drugs by biotechnology and pharmaceutical firms. Additionally, throughout the 2022–2029 forecast period, increasing interest in proteomics examination learnings is anticipated to fuel market growth.

  • Rising R&D expenditures

The market is expanding primarily due to rising glycomics research efforts, rising R&D expenditures by pharmaceutical and biotechnology firms, and expanding proteomics sales. On the other hand, developing nations like China and India provide profitable chances for business in this sector.

  • Rise in the geriatric population

The rising prevalence of disorders like diabetes and obesity, rising health-care spending, and the fast-growing diagnostic industry are driving the expansion of the global glycomics/glycobiology market.

Opportunities

The market for glycomics and glycobiology is being driven primarily by rising investments in research and development by pharmaceutical and biotechnology businesses and expansion in the proteomics sector. For other businesses in this industry, developing nations provide lucrative opportunities.

Restraints/Challenges

On the other hand, the huge expense of devices will obstruct the market's growth rate.

This glycomics/glycobiology market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the glycomics/glycobiology market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Glycomics/Glycobiology Market

In order to combat the COVID-19 epidemic, governments from all over the world work with pharmaceutical and biotech businesses. This collaboration ranges from helping to develop vaccines to preparing for issues with the pharmaceutical supply chain. Currently, there are 115 vaccine candidates and about 155 chemicals in the R&D pipeline. In addition, there has been a substantial rise in demand for commonly prescribed drugs like hydroxychloroquine, which is used to treat COVID-19. Due to the dearth of these treatments in many industrialised countries, there is a huge market opportunity for manufacturers of COVID-19 management therapies. The demand for COVID-19 vaccines and treatment drugs is expected to result in significant growth for the pharmaceutical and biotechnology industries in the upcoming years.

Global Glycomics/Glycobiology Market Scope

The glycomics/glycobiology market is segmented on the basis of product type, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

  • Enzymes
  • Glycosidases and Neuramidases
  • Glycosyltransferases and Sialytransferases
  • Other Enzymes
  • Carbohydrate kinases
  • Carbohydrate sulfotransferases
  • Protein sulfotransferases
  • Sulfatases
  • Instruments
  • Mass Spectrometry Instruments
  • Chromatography Instruments
  • Arrays
  • Other Instruments
  • electrophoresis instruments
  •  NMR instruments
  • HPLC columns
  • Kits
  • Glycan Releasing Kits
  • Glycan Labeling Kits
  • Glycan Purification Kits
  • Other Kits
  • Glycan detection kits
  • Glycan enrichment kits
  • Glycan sample preparation kits
  • Carbohydrates
  • Oligosaccharides
  • Monosaccharides
  • Other Carbohydrates
  • Rare sugars
  • Glycoproteins
  • Glycolipids
  • Glycol peptides
  • Reagents and Chemicals

Application

  • Drug Discovery and Development
  • Disease Diagnostics
  • Other Applications
  • Virology
  • Cell biology
  • Microbiology

End-user

  • Academic Research Institutes
  • Pharmaceutical and Biotechnology Companies
  • Clinical Laboratories

 Glycomics/Glycobiology Market Regional Analysis/Insights

The glycomics/glycobiology market is analysed and market size insights and trends are provided by country, product type, application and end-user as referenced above.

The countries covered in the glycomics/glycobiology market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the glycomics/glycobiology market due to increased funding for glycomics research, rising R&D spending in pharmaceutical companies for the creation of new medicines, and the close proximity of the necessary personnel.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 owing to the rising health awareness among the people and rising demand of advanced medical technology.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Glycomics/Glycobiology Market Share Analysis

The glycomics/glycobiology market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to glycomics/glycobiology market.

Some of the major players operating in the glycomics/glycobiology market are:

  • Merck KGaA (Germany)
  • Agilent Technologies Inc. (U.S.)
  • Thermo Fisher Scientific Inc. (U.S.)
  • Shimadzu Corporation (Japan)
  • Takara Bio Inc. (Japan)
  • Waters Corporation (U.S.)
  • Asparia Glycomics S.L. (Spain)
  • Bio-Techne (U.S.)
  • Bruker (U.S.)
  • Danaher (U.S.)
  • RayBiotech, Life Inc.  (U.S.)
  • Z Biotech LLC (U.S.)
  • Chemily Glycoscience (U.S.)
  • Dextra Laboratories Ltd. (U.K.)
  • Lectenz Bio (U.S.)
  • Ludger Ltd. (U.K.)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The glycomics/glycobiology market value is projected USD 47.44 billion by 2029.
The glycomics/glycobiology market is projected to grow at a CAGR of 14.2% during the forecast period of 2022-2029.
On the basis of product, the Glycomics/Glycobiology Market is segmented into Enzymes, Kits, Reagents and Chemicals, Instruments, Carbohydrates.
On the basis of application, the Glycomics/Glycobiology Market is segmented into Drug Discovery and Development, Disease Diagnostics, Other Application.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials